Hong Kong-listed Shandong Luoxin Pharmaceutical Group’s Privatization Offer

Kirkland & Ellis is advising Ally Bridge Group, as a joint offeror with a consortium established by an affiliate of the target company’s controlling shareholder and…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Michael Patrini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here